Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenetic Biosciences (XBIO) Asset Utilization Ratio (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.55 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 85.67% year-over-year to 0.55, compared with a TTM value of 0.55 through Sep 2025, up 85.67%, and an annual FY2024 reading of 0.29, changed N/A over the prior year.
  • Asset Utilization Ratio was 0.55 for Q3 2025 at Xenetic Biosciences, up from 0.44 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.55 in Q3 2025 and bottomed at 0.07 in Q1 2023.
  • Average Asset Utilization Ratio over 3 years is 0.28, with a median of 0.27 recorded in 2024.
  • Peak annual rise in Asset Utilization Ratio hit 250.8% in 2024, while the deepest fall reached 48.61% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.23 in 2023, then skyrocketed by 48.61% to 0.33 in 2024, then surged by 64.0% to 0.55 in 2025.
  • Business Quant data shows Asset Utilization Ratio for XBIO at 0.55 in Q3 2025, 0.44 in Q2 2025, and 0.41 in Q1 2025.